Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03624088 · ClinicalTrials.gov registry record · NA

CBPR - BRCA Genetic Testing Among Orthodox Jews

A NA study, sponsored by Columbia University.

Completed
Registry status
NA
Development phase
50
Enrollment target

NCT03624088 is a NA study that has completed, run by Columbia University. The registered enrollment target is 50 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03624088, a NA study, has completed, sponsored by Columbia University.

COMPLETED
Registry status
NA
Development phase
50 participants
Enrollment target

Study Summary

This study evaluates a web-based decision aid, named RealRisks, in promoting genetic testing intention among Orthodox Jewish women. 50 Orthodox Jewish women will take a baseline survey, self-administer the decision aid, and then complete two more surveys: one within one month of completing the decision aid and one at 6 months after completing the decision aid.

Interventions

  • BEHAVIORAL RealRisks

Trial Details

FieldValue
Enrollment Target 50 participants
Start Date 2018-03-13
Est. Completion 2019-01-29
Phase NA

Sponsor

Columbia University

958 total trials

What the Registry Record Tells You About NCT03624088

The ClinicalTrials.gov registry entry for NCT03624088 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Columbia University, which has 958 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 1 intervention - of which RealRisks is the first listed.

NCT03624088 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT03624088 about?

NCT03624088 is a clinical study titled "CBPR - BRCA Genetic Testing Among Orthodox Jews". This study evaluates a web-based decision aid, named RealRisks, in promoting genetic testing intention among Orthodox Jewish women. 50 Orthodox Jewish women will take a baseline survey, self-administer the decision aid, and then complete two more surveys: one within one month of completing the decis...

What is the current status of trial NCT03624088?

This trial is currently completed. It is a NA study. The enrollment target is 50 participants. The study started on 2018-03-13. Estimated completion is 2019-01-29.

What interventions are being tested in trial NCT03624088?

The interventions under investigation include: RealRisks (BEHAVIORAL).

Who is sponsoring clinical trial NCT03624088?

This trial is sponsored by Columbia University, which has 958 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.